5-75552473-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000241436.9(POLK):c.137G>A(p.Gly46Glu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,610,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000241436.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POLK | NM_016218.6 | c.137G>A | p.Gly46Glu | missense_variant, splice_region_variant | 3/15 | ENST00000241436.9 | |
POLK | NR_170560.3 | n.311G>A | splice_region_variant, non_coding_transcript_exon_variant | 4/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POLK | ENST00000241436.9 | c.137G>A | p.Gly46Glu | missense_variant, splice_region_variant | 3/15 | 1 | NM_016218.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151930Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247966Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134286
GnomAD4 exome AF: 0.0000391 AC: 57AN: 1458140Hom.: 0 Cov.: 30 AF XY: 0.0000427 AC XY: 31AN XY: 725420
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151930Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74210
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | The c.137G>A (p.G46E) alteration is located in exon 3 (coding exon 2) of the POLK gene. This alteration results from a G to A substitution at nucleotide position 137, causing the glycine (G) at amino acid position 46 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at